Your browser doesn't support javascript.
loading
N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells.
Liu, Zhihua; Zheng, Nanxin; Li, Juan; Li, Chao; Zheng, Dan; Jiang, Xue; Ge, Xiaoying; Liu, Min; Liu, Lianjie; Song, Zhen; Bao, Leilei; Zhan, Yangyang; Gao, Xianhua.
Afiliação
  • Liu Z; Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, China.
  • Zheng N; Department of Colorectal Surgery, Changhai Hospital, The First Affiliated Hospital of Naval Medical University, Shanghai, China; Hereditary Colorectal Cancer Center and Genetic Block Center of Familial Cancer, Changhai Hospital, The First Affiliated Hospital of Naval Medical University, Shanghai, Ch
  • Li J; Department of Nephrology, Changhai Hospital, The First Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Li C; Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, China.
  • Zheng D; Department of Pharmacy, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai, China.
  • Jiang X; Department of Pharmacy, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai, China.
  • Ge X; Department of Pharmacy, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai, China.
  • Liu M; Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, China.
  • Liu L; Department of Colorectal Surgery, Changhai Hospital, The First Affiliated Hospital of Naval Medical University, Shanghai, China; Hereditary Colorectal Cancer Center and Genetic Block Center of Familial Cancer, Changhai Hospital, The First Affiliated Hospital of Naval Medical University, Shanghai, Ch
  • Song Z; Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, China.
  • Bao L; Department of Pharmacy, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai, China. Electronic address: annabao212@126.com.
  • Zhan Y; Department of Pharmacy, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai, China. Electronic address: Zhany_biology@163.com.
  • Gao X; Department of Colorectal Surgery, Changhai Hospital, The First Affiliated Hospital of Naval Medical University, Shanghai, China; Hereditary Colorectal Cancer Center and Genetic Block Center of Familial Cancer, Changhai Hospital, The First Affiliated Hospital of Naval Medical University, Shanghai, Ch
Drug Resist Updat ; 65: 100886, 2022 12.
Article em En | MEDLINE | ID: mdl-36370665

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / MicroRNAs Limite: Humans Idioma: En Revista: Drug Resist Updat Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / MicroRNAs Limite: Humans Idioma: En Revista: Drug Resist Updat Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido